Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidental Detection of Respiratory Viruses in Lung Transplant Donor-Recipient Pairs: Exploratory Associations With Clinical Outcomes in a Post Hoc Analysis.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

Minimally invasive thymectomy: comparative analysis of short-term outcomes after video-assisted thoracoscopy and two robotic platforms.

Frontiers in surgery·2026
Same author

Uncontrolled donation after circulatory death lung transplantation program: Clinical outcomes and perspectives for implementation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Performance of the BioFire FilmArray Pneumonia Panel Plus Compared to Standard Microbiology in Lung Transplant Donor and Recipient Samples: A Prospective Cohort Study.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

Three Versus Two-Rows Circular Stapler in Colorectal Anastomosis: Short Term Outcomes.

Surgical innovation·2025
Same author

Sessile Serrated Lesions in Inflammatory Bowel Disease: Hidden Players in Colitis-Associated Colorectal Cancer?

Journal of clinical medicine·2025

Related Experiment Video

Updated: Jul 18, 2026

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
15:49

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System

Published on: October 16, 2013

[Inflammatory colitis: classification and surgical treatment].

Cinzia Baratti1, Alessia De Simone, Chiara Grassi

  • 1Università degli Studi di Milano, U.O.C. Chirurgia Generale I e. drboratticinzia@yahoo.it

Annali Italiani Di Chirurgia
|December 5, 2006
PubMed
Summary

Indeterminate colitis (IC) is a diagnostic category for inflammatory bowel disease when Crohn's disease (CD) or ulcerative colitis (UC) cannot be definitively diagnosed. Further research into serological markers may help classify IC patients for tailored treatments.

More Related Videos

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
08:20

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice

Published on: July 12, 2018

Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

Related Experiment Videos

Last Updated: Jul 18, 2026

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
15:49

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System

Published on: October 16, 2013

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
08:20

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice

Published on: July 12, 2018

Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

Area of Science:

  • Gastroenterology
  • Histopathology
  • Immunology

Context:

  • Inflammatory bowel disease (IBD) diagnosis presents challenges, leading to the classification of indeterminate colitis (IC).
  • Distinguishing between Crohn's disease (CD), ulcerative colitis (UC), and IC is crucial for treatment, prognosis, and surgical decisions.
  • Current guidelines for IC management, particularly surgical intervention, require further refinement based on limited studies.

Purpose:

  • To explore the diagnostic challenges and implications of indeterminate colitis (IC) within inflammatory bowel disease (IBD).
  • To review the current understanding of IC, its distinction from CD and UC, and the role of surgery.
  • To highlight the need for revised diagnostic criteria and potential for specific treatments based on emerging evidence.

Summary:

  • Indeterminate colitis (IC) is currently a diagnostic placeholder when definitive Crohn's disease (CD) or ulcerative colitis (UC) cannot be established via colonoscopy, biopsy, or colectomy.
  • The management and prognosis of IC differ significantly from CD and UC, with surgery being considered for severe or refractory cases.
  • Emerging research on serological markers like ASCA and P-ANCA suggests that IC may represent distinct subgroups requiring specific therapeutic approaches, moving beyond a diagnosis of exclusion.

Impact:

  • Clarifying the diagnostic criteria for IC will improve patient management and treatment selection.
  • Identifying distinct subgroups within IC through serological markers can lead to personalized medicine strategies.
  • Revisiting the role of surgery in IC management based on evidence will optimize patient outcomes.